A detailed history of W Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, W Advisors, LLC holds 542 shares of LLY stock, worth $405,421. This represents 0.3% of its overall portfolio holdings.

Number of Shares
542
Previous 545 0.55%
Holding current value
$405,421
Previous $493,000 2.64%
% of portfolio
0.3%
Previous 0.32%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $2,316 - $2,880
-3 Reduced 0.55%
542 $480,000
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $2,174 - $2,727
3 Added 0.55%
545 $493,000
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $1,776 - $2,376
3 Added 0.56%
542 $421,000
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $2,100 - $2,476
-4 Reduced 0.74%
539 $314,000
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $2,608 - $3,595
-6 Reduced 1.09%
543 $291,000
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $2,805 - $3,751
-8 Reduced 1.44%
549 $257,000
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $179,103 - $208,691
557 New
557 $203,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track W Advisors, LLC Portfolio

Follow W Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of W Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on W Advisors, LLC with notifications on news.